The Effects of Ganciclovir and Valganciclovir Antiviral Treatments in Children with Congenital Cytomegalovirus Infection
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Author
Centola, AllysonDate Published
2016
Metadata
Show full item recordAbstract
Congenital cytomegalovirus (cCMV) is one of the leading causes of non-hereditary newborn hearing losses. Typically children with a hearing loss would receive amplification to help combat the loss; however, new research has shown that children who have cCMV can receive antiviral treatments in lieu of amplification. Ganciclovir and valganciclovir are the antiviral treatments that are currently being used. These antiviral treatments help eliminate the viral load in the blood and thus improve the child’s hearing loss.Description
Senior capstone poster, Department of Communication Sciences and Disorders, SUNY Plattsburgh